Avacta makes progress with development of affimer candidates
Avacta is using affimers to develop its own cancer therapy, but it also licenses the technology to other companies, including major pharma group ModernaTX and LG Chem Life Sciences
Company
Avacta Group PLC
LON:AVCT
At Avacta we have developed Affimer technology, an engineered alternative to antibodies. Based on a small protein, Affimer technology can be quickly developed to bind with high specificity and affinity to a wide range of targets. Affimer proteins can be developed as therapeutic molecules and can be used in a wide range of other life sciences applications in research and diagnostics.
207 stories · page 4 of 11
Investments and investor services
Vp hit by Competition and Markets Authority decision
A look at the day's major movers, including The Mission Marketing Group, Sirius Minerals, 7digital, Nuformix, Defenx and Shearwater
Archive
Proactive news snapshot: ReNeuron, AFC Energy, Collagen Solutions, AppScatter …
A glance at some of the day's highlights from the Proactive Investors newswire
Avacta well-cashed and on track to begin clinical trial of first Affimer therapeutic next year
The first Affimer-based therapeutic is PD-L1 is a potential cancer treatment that helps the immune system to identify and attack cancer cells
Investments and investor services
FTSE 100 closes in the red as Brexit and trade war fears continue to hit sentiments
The International Monetary Fund issued a warning, saying a "no-deal" Brexit would send the British economy into severe shock
Archive
Sumo no heavyweight but finals should show good development, yet unlikely to divert from Brexit
The Day Ahead will continue to be dominated by the Brexit saga, with the corporate news diary limited to small cap firms, including City Pubs Group, Destiny Pharma
Archive
Retailers Tesco and ASOS to provide the main corporate excitement in coming week
Also on the retail front, WH Smith and Dunelm will issue updates as well in the Week Ahead, while on the macro front an ECB rate decision and US FOMC meeting minutes are also due
Archive
Proactive news snapshot: Diversified Gas & Oil, Seeing Machines, PCF Group …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Proactive news snapshot: Tissue Regenix, Avacta Group, Mkango Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Tri-Star shines bright as it awaits first antimony ingot from Oman
Some of the main news-driven risers and fallers in London on Monday…
Avacta says partner Moderna takes collaboration to next level
The US-listed group has triggered an exclusivity option. Chief executive Dr Alastair Smith said: "This is further strong validation of the potential of the Affimer drug platform to generate differentiated therapeutic molecules for developme
Investments and investor services
FTSE 100 closes a shade higher as Wall Street chugs upward
The UK's premier share index added nearly 14 points to close at 7,034
Archive
Proactive news snapshot: Kavango Resources, Futura Medical, Kromek …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
SimplyBiz full of zest as Taylor Wimpey joins the customer list
A look at the day's major movers, including Sensyne Health, Reabold Resources, Maintel, Nu-Oil, Altona Energy, Flybe and PCI-PAL
Investments and investor services
FTSE 100 closes lower as trade worries dent global equities; Ocado top Footsie gainer
A deceptively dull start by the Footsie gradually turned into something a bit more dramatic
Avacta Group trading in line in "year of very significant progress"
An update on the collaboration with Moderna is planned for the first half of this year
Archive
Proactive news snapshot: Redx Pharma, Ariana Resources, Avacta Group …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Nakama stumbles in final quarter of 2018
A look at the day's major movers, including Panthera Resources, Filtronic, Keystone Law, MOD Resources and Modern Water
Investments and investor services
FTSE 100 nudges lower at close as China growth worries hit stocks
The UK's blue-chip index finished down nearly seven points at 6,96, while FTSE 250 was also lower